Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Share Price
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 EGP | -3.60% | -14.06% | +29.70% |
Sales 2024 * | 2.92B 61.14M 5.1B | Sales 2025 * | 3.21B 67.34M 5.61B | Capitalization | 3.19B 66.84M 5.57B |
---|---|---|---|---|---|
Net income 2024 * | 361M 7.57M 631M | Net income 2025 * | 485M 10.16M 847M | EV / Sales 2024 * | 1.46 x |
Net Debt 2024 * | 1.07B 22.35M 1.86B | Net Debt 2025 * | 766M 16.05M 1.34B | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
7.47
x | P/E ratio 2025 * |
6.8
x | Employees | - |
Yield 2024 * |
3.18% | Yield 2025 * |
4.79% | Free-Float | 50.28% |
1 day | -3.60% | ||
1 week | -14.06% | ||
Current month | -17.69% | ||
1 month | -25.44% | ||
3 months | +14.13% | ||
6 months | +34.85% | ||
Current year | +29.70% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 01/11/01 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 01/19/01 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 01/20/01 |
Director/Board Member | 65 | 01/19/01 | |
Director/Board Member | - | 01/11/01 |
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 2.14 | -3.60% | 9 835 275 |
24/24/24 | 2.22 | -6.33% | 13,400,680 |
23/24/23 | 2.37 | -5.58% | 5,209,276 |
22/24/22 | 2.51 | -1.18% | 4,664,347 |
21/24/21 | 2.54 | +2.01% | 3,522,580 |
End-of-day quote Egyptian Exchange, April 28, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.70% | 69.08M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- RMDA Stock